Saturday,
08 August 2020

Sinovac Biotech Ltd.

Japan in deals with AstraZeneca, Novavax for COVID-19 vaccines (1)
REUTERS August 8, 2020 at 07:55 JST Japan plans to buy AstraZeneca Plc's experimental COVID-19 vaccine and fund a local company to manufacture Novavax's vaccine candidate, ramping up its stockpile plan as it battles surging infections. Japan will order 120 million doses of the experimental vaccine developed by the British pharmaceutical company, beginning with 30 million doses by March next year.
In news